oteseconazole

oteseconazole

oteseconazole Mycovia Pharmaceuticals Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis  DURHAM, N.C.–(BUSINESS…

Read More
ruxolitinib

ruxolitinib

ruxolitinib Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis WILMINGTON, Del.–(BUSINESS WIRE)…

Read More
Nefecon

Nefecon

Calliditas Announces Submission of New Drug Application to U.S. FDA for Nefecon in Patients with Primary IgA Nephropathy Mar 15, 2021 — Calliditas Therapeutics AB…

Read More